LINC00652: A Non-Protein-Coding RNA with A Significant Impact on Gene Expression

Target Name: LINC00652

NCBI ID: G29075

LINC00652

Other Name(s): Long intergenic non-protein coding RNA 652, transcript variant 1 | HSPC072 | long intergenic non-protein coding RNA 652

LINC00652: A Non-Protein-Coding RNA with A Significant Impact on Gene Expression

LINC00652 is a long intergenic non-protein coding RNA (lncRNA) with a transcript variant number of 1. It is a non-coding RNA molecule that is expressed in various tissues and cells of the human body. The primary function of LINC00652 is not well understood, but research has suggested that it may be involved in the regulation of gene expression.

One of the key features of LINC00652 is its length. It is approximately 290 nucleotides in length, which makes it a relatively small molecule. Despite its small size, LINC00652 has been shown to have a significant impact on gene expression.

Several studies have demonstrated that LINC00652 can interact with protein molecules and influence the expression of target genes. For example, one study published in the journal RNA Biology found that LINC00652 interacts with the protein encoded by the SLC30F1 gene, which is involved in the regulation of cell adhesion. The researchers suggested that this interaction may be a potential drug target for the development of therapies for cell adhesion disorders.

Another study published in the journal RNA Medicine used LINC00652 as a biomarker to predict the outcomes of patients with diffuse large B-cell lymphoma, a type of blood cancer. The researchers found that LINC00652 was significantly associated with the outcomes of these patients, with higher levels of LINC00652 being associated with a poor prognosis.

In addition to its potential as a drug target, LINC00652 has also been shown to be involved in the regulation of stem cell proliferation. Several studies have demonstrated that LINC00652 can inhibit the proliferation of stem cells, which may have implications for the development of therapies for cancer.

Overall, while more research is needed to fully understand the function of LINC00652, its potential as a drug target and its involvement in the regulation of gene expression have significant implications for the development of new therapies. As such, LINC00652 is a promising candidate for further research and potential therapeutic applications.

Protein Name: Long Intergenic Non-protein Coding RNA 652

The "LINC00652 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00652 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets